NCT01357499

Brief Summary

The purpose of this study is to investigate if remote ischemic preconditioning by combining limb ischaemia with electric muscle stimulation of the ischemic muscle provokes better results in preconditioning the human heart than limb ischaemia alone does.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2011

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 20, 2011

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

November 16, 2016

Status Verified

November 1, 2016

Enrollment Period

3 years

First QC Date

May 10, 2011

Last Update Submit

November 15, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • ST deviation

    Immediately after the preconditioning cycle the PCI ballon will be positioned in the coronary artery lesion and inflated for 2 minutes followed by 5 minutes of reperfusion. This cycle will be repeated for 3 times without any interruption. Intracoronary ECGs and 12 lead surface ecgs will be taken immediately before and at the end of each ballon inflation (two minutes after beginning the intracoronary ballon inflation). after taking the ecgs the ballon will be deflated. The st-deviations will be analysed.

    120 seconds after angioplasty

Secondary Outcomes (2)

  • troponin I

    24 hours after PCI

  • chest pain (Maximum)

    time period 2 minutes

Study Arms (3)

control group

A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg but without inflating the cuff and without stimulating the muscle. Now 25 minutes will have to pass by before beginning the coronary angioplasty.

intervention group 1

A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg. The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes. Next reperfusion will be allowed for 5 minutes. This cycle will be repeated for 3 times. There will be no electrical muscle stimulation in this group.

Device: blood pressure cuff

intervention group 2

A Blood pressure cuff and the muscle stimulator pads will be applied to one lower leg. The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes. Next reperfusion will be allowed for 5 minutes. This cycle will be repeated for 3 times. In addition electrical muscle stimulation will be performed throughout the whole preconditioning cycle

Device: blood pressure cuff + electric muscle stimulator

Interventions

A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg. The blood pressure cuff will be inflated with 200 mmHg for 5 minutes. Next reperfusion will be allowed for 5 minutes. This cycle will be repeated for 3 times.

intervention group 1

A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg. The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes. Next reperfusion will be allowed for 5 minutes. This cycle will be repeated for 3 times. In addition electrical muscle stimulation will be performed throughout the whole preconditioning cycle.

intervention group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing elective PCI fulfilling the inclusion and exclusion criteria.

You may qualify if:

  • planned PCI of one of the main coronary artery (artery diameter distal of the stenotic area at least 2,5 mm)
  • patient age 18 years or older
  • stable angina pectoris symptoms

You may not qualify if:

  • presence of collateral vessels
  • electrocardiographic bundle branch blocks
  • multiple coronary stenosis
  • occlusion of a coronary artery
  • renal insufficiency (GFR (MDRD) \< 50 ml/min/1,73 m2)
  • presence of coronary bypass grafts
  • history or presence of myocardial infarction.
  • echocardiographic signs of left ventricular hypertrophy (septal and/or posterior wall diameter greater than 14 mm)
  • some sort of medications (adenosine, morphine and derivates, immunosuppressive agents, oral antibiotics, theophyllin, alpha receptor blockers)
  • peripheral arterial disease
  • exercise tests performed within 24 h before study start.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ernst Moritz Arndt Universität Greifswald

Greifswald, MVP, 17489, Germany

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

venous blood samples (10 ml) will be taken from the femoral vein of the preconditioned leg immediately before and after the preconditioning cycles. Also arterial blood samples (10 ml)will be taken immediately before and after the preconditioning cycle.

MeSH Terms

Conditions

Myocardial Ischemia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Markus Reinthaler, MD

    Ernst Moritz Arndt University Greifswald

    PRINCIPAL INVESTIGATOR
  • Thorsten Reffelmann, MD

    Ernst Moritz Arndt University Greifswald

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 10, 2011

First Posted

May 20, 2011

Study Start

December 1, 2010

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

November 16, 2016

Record last verified: 2016-11

Locations